; and (2) in subsection (k)(1)(B)— (A) in subclause (IV), by striking and at the end; (B) in subclause (V), by striking the period and inserting ; and ; and (C) by adding at the end the following new subclause: (VI) any prices described in subsection (c)(1)(C)(i)(VII). . (b) Outreach to manufacturers The Secretary of Health and Human Services shall notify drug manufacturers of the amendments made by subsection (a) through an electronic communication through MLN Connects or such other method as determined appropriate by the Secretary.